| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.05 |
| mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.091 |
0.05 |
| mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.05 |
| mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.05 |
| mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.05 |
| mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.05 |
| mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.35 |
0.05 |